EPSTATE SR 150: Epalrestat 150 mg Uses, Benefits, Side Effects & Price in India

 EPSTATE SR 150 is a prescription medicine containing Epalrestat 150 mg, marketed by Steris Healthcare Pvt. Ltd. in India. Epalrestat belongs to a class of medicines known as aldose reductase inhibitors and is used in the management of diabetic peripheral neuropathy, a complication of diabetes that affects nerves, particularly those in the hands and feet.

Diabetic neuropathy may cause burning sensations, tingling, numbness, discomfort, or changes in sensation. EPSTATE SR 150 is intended for use under medical supervision as part of an individualized diabetes care plan. Its suitability depends on the patient's symptoms, medical history, blood glucose management, and the prescribed formulation.

For people searching for Epalrestat 150 mg tablets in India, EPSTATE SR 150 by Steris Healthcare is an option to discuss with a qualified healthcare professional. Before purchasing, verify the composition, dosage form, pack size, and current availability through the product listing or an authorized pharmacy.

What Is EPSTATE SR 150 Used For?

EPSTATE SR 150 is used for the management of diabetic peripheral neuropathy when prescribed by a doctor. This condition develops when diabetes-related metabolic changes affect peripheral nerves. Symptoms may include burning pain, pins-and-needles sensations, numbness, and reduced sensitivity in the feet or hands.

Epalrestat targets a biochemical pathway associated with high blood glucose levels and nerve damage. It is not a substitute for diabetes treatment, blood glucose monitoring, foot care, or other prescribed medicines. Not all nerve symptoms in people with diabetes are caused by diabetic neuropathy, so an appropriate medical assessment is important before treatment begins.

Why Is Epalrestat 150 mg Important?

Long-term elevated blood glucose can contribute to nerve damage and other diabetes-related complications. Managing blood glucose, blood pressure, cholesterol, and other risk factors is an important part of reducing the risk of further complications.

Epalrestat works differently from conventional pain-relieving medicines because it inhibits an enzyme involved in the polyol pathway. This pathway has been associated with metabolic changes that may contribute to diabetic nerve injury.

For patients in India living with diabetes, early recognition of symptoms and regular medical follow-up are important. Persistent numbness, reduced sensation, or foot injuries should not be ignored, as nerve damage can make wounds harder to notice.

Key Benefits of EPSTATE SR 150

EPSTATE SR 150 contains Epalrestat 150 mg, which acts on a metabolic pathway associated with diabetic neuropathy. Its clinical benefits depend on the patient's condition and response to treatment.

What Are the Benefits of Epalrestat 150 mg?

  • Targets a specific metabolic pathway: Epalrestat inhibits aldose reductase, an enzyme involved in the conversion of glucose to sorbitol.
  • Supports diabetic neuropathy management: It may be prescribed to manage diabetic peripheral neuropathy in suitable patients.
  • Addresses an underlying biochemical process: Its mechanism differs from that of medicines used solely to relieve pain.
  • Forms part of comprehensive diabetes care: It can be used alongside appropriate blood glucose management and other treatments prescribed by a healthcare professional.

These benefits should not be interpreted as a guarantee that nerve damage will be reversed or that symptoms will disappear. Individual results vary, and ongoing diabetes management remains essential.

Mechanism of Action of EPSTATE SR 150

Epalrestat is an aldose reductase inhibitor. In the polyol pathway, the enzyme aldose reductase converts glucose into sorbitol. When blood glucose remains elevated, increased activity in this pathway may contribute to sorbitol accumulation and metabolic stress in nerve tissues.

By inhibiting aldose reductase, Epalrestat reduces activity in this pathway. This may help address one of the biochemical processes associated with diabetic peripheral neuropathy.

The medicine's action does not replace the need to maintain appropriate blood glucose levels. Your doctor can explain how Epalrestat fits into your overall treatment plan and whether further monitoring is necessary.

Side Effects of EPSTATE SR 150

Like other medicines, Epalrestat may cause side effects in some people. Possible adverse effects include:

  • Nausea or stomach discomfort.
  • Digestive disturbances.
  • Skin rash or itching.
  • Headache or dizziness.
  • Changes in liver function tests.

Not everyone experiences side effects. Contact your healthcare professional if symptoms persist, worsen, or cause concern.

Serious Side Effects of Epalrestat 150 mg

Seek prompt medical attention if you develop signs of a serious reaction, including:

  • Yellowing of the skin or eyes, dark urine, or unusual fatigue, which may indicate a liver problem.
  • Severe or widespread skin rash, facial swelling, or difficulty breathing, which may indicate an allergic reaction.
  • Persistent vomiting or severe abdominal discomfort.

Inform your doctor about unexpected symptoms, particularly if you have existing liver disease or take other medicines that may affect liver function. Your healthcare professional can determine whether treatment should be stopped or further tests are needed.

Available Substitutes for EPSTATE SR 150

If EPSTATE SR 150 is unavailable or unsuitable, a doctor or pharmacist may identify another approved Epalrestat product with an appropriate strength and formulation.

Before choosing an alternative, compare the active ingredient, strength, release characteristics, manufacturer, and product quality. Different brands are not necessarily interchangeable simply because they contain Epalrestat. Do not switch medicines or change your dosage without professional advice.

Dosage Guidelines for EPSTATE SR 150

The appropriate dose and duration depend on your prescription, the exact formulation, and your medical circumstances.

  • Take EPSTATE SR 150 only as directed by your doctor.
  • Follow the instructions printed on the dispensing label and packaging.
  • If the product is an extended-release or delayed-release tablet, swallow it as instructed; do not crush or chew it unless a healthcare professional confirms this is appropriate.
  • Do not increase the dose or take an additional tablet after a missed dose without medical advice.
  • Continue monitoring your blood glucose as directed.
  • Attend follow-up appointments and complete recommended laboratory tests.

Do not assume that every Epalrestat 150 mg product has the same release characteristics or dosing schedule. Confirm the instructions for the exact product supplied.

Precautions and Warnings

Before using EPSTATE SR 150, tell your healthcare professional about your medical history, allergies, liver problems, pregnancy or breastfeeding status, and all medicines or supplements you take.

  • Liver health: Epalrestat treatment may require attention to liver function. Report symptoms such as jaundice or dark urine promptly.
  • Pregnancy and breastfeeding: Seek medical advice before use because suitability depends on the clinical circumstances and available safety information.
  • Other medicines: Provide your doctor with a complete list of your medicines to help assess possible interactions.
  • Diabetes management: Continue prescribed diabetes medicines, blood glucose checks, and dietary recommendations unless your doctor advises otherwise.
  • Foot care: Inspect your feet regularly and seek medical care for wounds, ulcers, swelling, or signs of infection.
  • Self-medication: Do not use Epalrestat for unexplained numbness or nerve pain without a proper diagnosis.

Store the medicine according to its packaging instructions and keep it out of reach of children.

Conclusion

EPSTATE SR 150 by Steris Healthcare contains Epalrestat 150 mg, an aldose reductase inhibitor used in the management of diabetic peripheral neuropathy. By acting on the polyol pathway, Epalrestat targets a metabolic process associated with diabetes-related nerve complications.

For patients in India, appropriate diagnosis, careful monitoring, blood glucose management, and adherence to prescribed treatment are essential. Before purchasing EPSTATE SR 150 online, confirm the current composition and release formulation, review the safety information, and consult a qualified healthcare professional to determine whether it is suitable for your needs.

Comments

Popular posts from this blog

Steris Healthcare: Committed to Quality Healthcare and Pharmaceutical Excellence

N-Acetyl L-Cysteine (NAC), Pine Bark Extract and Resveratrol Tablets for Daily Wellness